Bioventix PLC Stock OTC Markets
Stocks
BVNXF
GB00B4QVDF07
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| 30/03 | BioVentix confident on future despite profit decline in first half | AN |
| 30/03 | WINNERS & LOSERS: boohoo to beat view; Abingdon Health wins deals | AN |
| Market Cap | 88.82M 118M 104M 98.39M 167M 11.31B 170M 1.18B 453M 5.78B 443M 433M 18.53B | P/E 2026 * |
12.7x | P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 83.93M 111M 98.12M 92.97M 158M 10.68B 160M 1.11B 428M 5.46B 418M 409M 17.51B | EV / Sales 2026 * |
6.71x | EV / Sales 2027 * | - |
| Free-Float |
92.29% | Yield 2026 * |
8.82% | Yield 2027 * | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Peter Harrison
CEO | Chief Executive Officer | 67 | 23/12/2003 |
| Director of Finance/CFO | 67 | 01/07/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Peter Harrison
BRD | Director/Board Member | 67 | 25/11/2010 |
Ian Nicholson
CHM | Chairman | 66 | 01/11/2004 |
| Director/Board Member | 67 | 01/07/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 114M | |
| +4.16% | -0.30% | +58.96% | +94.17% | 71.53B | |
| -0.19% | -1.01% | +38.55% | +83.85% | 60.12B | |
| -1.51% | +2.20% | +10.66% | +35.15% | 48.85B | |
| -0.05% | -0.46% | +48.77% | +36.65% | 44.28B | |
| +0.38% | +6.43% | +345.54% | +641.55% | 43.83B | |
| +0.18% | -0.58% | +9.95% | +103.45% | 41.53B | |
| -0.67% | -0.45% | +4.47% | +46.37% | 30.13B | |
| +4.77% | +6.46% | +41.54% | +22.78% | 27.98B | |
| -1.29% | -5.53% | -19.42% | +352.04% | 25.25B | |
| Average | +0.62% | +0.48% | +59.89% | +157.33% | 43.72B | |
| Weighted average by Cap. | +0.85% | +0.63% | +65.00% | +148.55% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 12.5M 16.6M 14.61M 13.85M 23.56M 1.59B 23.86M 166M 63.75M 813M 62.31M 60.96M 2.61B | - |
| Net income | 7.11M 9.44M 8.31M 7.88M 13.4M 905M 13.58M 94.25M 36.27M 463M 35.45M 34.68M 1.48B | - |
| Net Debt | -4.89M -6.5M -5.72M -5.42M -9.22M -623M -9.34M -64.86M -24.96M -318M -24.4M -23.87M -1.02B | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BVXP Stock
- BVNXF Stock
Select your edition
All financial news and data tailored to specific country editions
